Utilization of sulfur and other mineral elements by growing dairy heifers treated with bovine somatotropin.
Apparent absorption and retention of Ca, P, Mg, K, Cu, Mn, Zn, and S were determined in Holstein heifers treated with recombinant bovine somatotropin (bST). Six heifers (initial BW averaged 104 kg) were assigned to various doses of bST in a 6 x 6 Latin square design with six consecutive 21-d periods. Treatments were daily i.m. injections of 0, 6.7, 33.3, 66.7, 100, or 200 micrograms of bST/kg of BW on d 8 to 21 of each period. All heifers were fed a hay-concentrate diet, and nutrient digestibilities and balances were determined on d 14 to 20 of each period. Mineral concentrations in feed, water, excreta, and blood plasma were determined with an inductively coupled argon plasma-emission spectrometer. Exogenous bST did not affect apparent absorption or retention of Ca, P, Mg, K, Cu, Mn, or Zn. Plasma CU concentration was greater (P less than .05) in heifers receiving bST (82 micrograms of Cu/dl) than in those receiving excipient (73 micrograms of Cu/dl); plasma concentrations of other elements were not affected by bST. Injection of bST did not affect S absorption, but urinary S excretion decreased (P less than .05) and S retention increased (P less than .05) as dose of bST increased. The amount of S retained (1.5 g/d) when the heifers received the largest dose of bST was approximately 50% greater than the amount retained when heifers received excipient. These results demonstrate that bST affects the postabsorptive metabolism of S. Generally, bST did not affect nutrient digestibilities. Effects of bST on dietary mineral requirements were not determined because of the relatively short (14 d) treatment periods.
House
W A
WA
USDA-ARS, Plant, Soil and Nutr. Lab., Ithaca, NY 14853.
Crooker
B A
BA
Bauman
D E
DE
D000818:Animals; D002417:Cattle / Q000254:growth & development / Q000378:metabolism* / Q000502:physiology; D004063:Digestion / Q000187:drug effects; D004326:Drinking / Q000187:drug effects; D004435:Eating; D005260:Female; D013006:Growth Hormone / Q000008:administration & dosage / Q000494:pharmacology*; D007273:Injections, Intramuscular / Q000662:veterinary; D007408:Intestinal Absorption / Q000187:drug effects*; D008903:Minerals / Q000378:metabolism*; D011897:Random Allocation; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000494:pharmacology; D013455:Sulfur / Q000378:metabolism*; D015430:Weight Gain
D008903:Minerals; D011994:Recombinant Proteins; D013455:Sulfur; D013006:Growth Hormone